|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.480 USD | -4.92% |
|
+2.35% | +82.20% |
| 06-29 | C4 Therapeutics, Inc.(NasdaqGS:CCCC) added to Russell 2000 Index | CI |
| 06-29 | C4 Therapeutics, Inc.(NasdaqGS:CCCC) added to Russell 2000 Value Benchmark | CI |
| Market Cap | 385M 334M 311M 286M 540M 36.73B 548M 3.67B 1.44B 18.29B 1.45B 1.41B 61.32B | P/E 2026 * |
-3.72x | P/E 2027 * | -3.46x |
|---|---|---|---|---|---|
| Enterprise Value | 385M 334M 311M 286M 540M 36.73B 548M 3.67B 1.44B 18.29B 1.45B 1.41B 61.32B | EV / Sales 2026 * |
20.3x | EV / Sales 2027 * | 20.1x |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: C4 Therapeutics, Inc.
| 1 day | -4.92% | ||
| 1 week | +2.35% | ||
| 1 month | -19.82% | ||
| 3 months | +19.18% | ||
| 6 months | +83.16% | ||
| Current year | +82.20% |
| 1 week | 3.41 |  | 3.71 |
| 1 month | 3.39 | | 4.42 |
| Current year | 1.69 | | 5.17 |
| 1 year | 1.69 | | 5.17 |
| 3 years | 1.06 | | 11.88 |
| 5 years | 1.06 | | 51.21 |
| 10 years | 1.06 | | 51.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 55 | 02/10/2020 |
Kendra Adams
DFI | Director of Finance/CFO | 49 | 18/09/2023 |
Paige Mahaney
CTO | Chief Tech/Sci/R&D Officer | 56 | 28/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenneth Anderson
BRD | Director/Board Member | 74 | 01/12/2015 |
Andrew Hirsch
BRD | Director/Board Member | 55 | 14/09/2020 |
Utpal Koppikar
BRD | Director/Board Member | 55 | 16/03/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Fiscal year | Chief Technology Officer | 22,722 | 0.0206% | ||
| 01/07/26 | Free | Director | 3,341 | 0.0030% | ||
| 01/07/26 | Free | Founder | 2,650 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.92% | +2.35% | +64.15% | -6.20% | 385M | |
| -1.40% | +2.59% | -1.71% | +11.28% | 48.53B | |
| -2.41% | -0.90% | +411.96% | +495.33% | 39.87B | |
| -1.16% | +12.96% | +28.81% | +7.25% | 38.68B | |
| -1.88% | -3.03% | +5.69% | +53.00% | 35.13B | |
| -1.74% | +5.12% | +14.44% | +41.77% | 29.79B | |
| -0.21% | -4.04% | +36.40% | +125.75% | 16.11B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| -0.64% | +2.65% | +3.40% | +13.11% | 13.61B | |
| -1.19% | -1.32% | -1.73% | -34.37% | 12.62B | |
| Average | -1.84% | +1.18% | +62.38% | +78.55% | 25.08B | |
| Weighted average by Cap. | -1.60% | +2.03% | +79.76% | +108.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.92M 16.45M 15.31M 14.06M 26.55M 1.81B 26.96M 180M 70.84M 899M 71.07M 69.51M 3.02B | 19.14M 16.64M 15.49M 14.22M 26.85M 1.83B 27.27M 183M 71.64M 910M 71.88M 70.3M 3.05B |
| Net income | -119M -104M -96.43M -88.54M -167M -11.38B -170M -1.14B -446M -5.66B -448M -438M -18.99B | -151M -131M -122M -112M -211M -14.39B -215M -1.44B -564M -7.16B -566M -554M -24.02B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $3.480 | -4.92% | 1,949,817 |
| 30/07/26 | $3.660 | +3.98% | 3,149,151 |
| 29/07/26 | $3.520 | -0.85% | 2,222,144 |
| 28/07/26 | $3.550 | -1.11% | 2,373,141 |
| 27/07/26 | $3.590 | +5.59% | 4,272,014 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CCCC Stock
Select your edition
All financial news and data tailored to specific country editions
